Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence

MS De Lima, M Hotopf - Drug safety, 2003 - Springer
Background: Dysthymia is a prevalent form of subthreshold depressive disorder, associated
with considerable disability and high co-morbidity. This paper systematically appraises the …
被引用次数：46 相关文章

Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.

MS De Lima, M Hotopf - Drug Safety, 2003 - europepmc.org
Background Dysthymia is a prevalent form of subthreshold depressive disorder, associated
with considerable disability and high co-morbidity. This paper systematically appraises the …

Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence

MS De Lima, M Hotopf - Drug safety, 2003 - pubmed.ncbi.nlm.nih.gov
Background Dysthymia is a prevalent form of subthreshold depressive disorder, associated
with considerable disability and high co-morbidity. This paper systematically appraises the …

Benefits and risks of pharmacotherapy for dysthymia-A systematic appraisal of the evidence

MS De Lima, M Hotopf - Drug Safety, 2003 - kclpure.kcl.ac.uk
Background: Dysthymia is a prevalent form of subthreshold depressive disorder, associated
with considerable disability and high co-morbidity. This paper systematically appraises the …

[引用][C] Benefits and risks of pharmacotherapy for dysthymia: A systematic appraisal of the evidence

MS DE LIMA, M HOTOPF - Drug safety, 2003 - pascal-francis.inist.fr
Benefits and risks of pharmacotherapy for dysthymia: A systematic appraisal of the evidence
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

[引用][C] Benefits and risks of pharmacotherapy for dysthymia: A systematic appraisal of the evidence

MS DE LIMA, M HOTOPF - Drug safety, 2003 - Adis International